Why the study?
Does perioperative beta blocker medication reduce the incidence and severity of major cardiovascular events in patients undergoing major non-cardiac surgery?
Does perioperative beta blocker medication reduce the incidence and severity of major cardiovascular events in patients undergoing major non-cardiac surgery?
Answers are grounded in this paper and cite their sources.
Perioperative beta-blockade remains a controversial practice aimed at reducing major cardiovascular events in non-cardiac surgery.
As anaesthetists, one of our primary objectives is to prevent complications in the perioperative period. Cardiovascular complications, in particular, are a leading cause of morbidity and mortality. The introduction of beta blocker medication around the time of major non-cardiac surgery continues to be one of the most controversial practices in perioperative medicine. The practice targets a reduction in the incidence and severity of major cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Lawson Rb (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: